Rachel Geman, a partner in the New York office, combats frauds that harm her clients in their lives and misconduct that threatens the fairness and safety of their workplaces.
Recent successes and exemplar ongoing matters:
- Co-Lead Counsel in consumer privacy litigation against fintech company Plaid (2022 settlement of $58 million and robust injunctive relief)
- Lead Counsel for whistleblowers in matter involving fraud in New York’s Indigent Care Program against the Door (2022 settlement of $12.9 million)
- Plaintiffs’ Steering Committee member in the Valsartan contaminated drug litigation (ongoing)
- Lead Counsel for the whistleblower in litigation against AbbVie involving the marketing of Humira (2020 settlement of $24 million)
- Represented consumers in the GM Ignition Switch MDL economic loss litigation (2020 settlement of $121 million)
- Co-Lead Counsel representing the City of Philadelphia in Fair Housing Act litigation against Wells Fargo (2019 settlement with the bank’s funding city programs for communities affected by lending discrimination and agreeing to other relief)
- Exemplar earlier cases: Rachel was co-lead class counsel or counsel for the class in consumer financial litigation over “payment protection” products, resulting in more than $50 million in settlements; she represented employee benefit plans in recovering $65 million from AXA Rosenberg; she represented a class of female financial advisors who secured $39 million plus injunctive relief from Bank of America/Merrill Lynch to settle gender discrimination claims; and she cut her teeth in the False Claims Act years ago in helping to recoup $78.5 million from the University of Phoenix in one of the largest settlements involving fraud on the Department of Education.
Rachel is the employee-side chair of the ABA’s Workplace and Occupational Safety and Health Law Committee; the chair of the NELA/NY amicus committee; and a CDRC-trained community mediator.
Long form bio (click to open pdf).